sumatriptan has been researched along with morphine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brockmöller, J; Friesacher, HR; Meyer, MJ; Neumann, VE; Tzvetkov, MV; Zdrazil, B | 1 |
| Busch, M; Jasinski, DR; Preston, KL; Sullivan, JT; Testa, MP | 1 |
| Hansen, AJ; Ingvardsen, BK; Laursen, H; Olsen, UB | 1 |
| Benkelfat, C; Bienstock, CA; Greenberg, BD; Hollander, E; Koran, LM; Marazziti, D; Pallanti, S; Rasmussen, SA; Ravizza, L; Sasson, Y; Saxena, S; Zohar, J | 1 |
| Lychkova, AE | 1 |
| Alstadhaug, K; Breivik, K; Rusic, Z | 1 |
| Akbarian, R; Amini-Khoei, H; Dehpour, AR; Fatemi, I; Hassanipour, M; Jalali, M; Nazari, A; Rahimi, N; Rajai, N; Shahabaddini, A | 1 |
| Dodick, DW; Nation, KM; Navratilova, E; Porreca, F | 1 |
| Johansen, SS; Linnet, K; Nielsen, MKK; Wang, X | 1 |
| Crombie, A; Dripps, I; Moye, LS; Pradhan, AA; Sheets, Z; Tipton, AF; Violin, JD | 1 |
2 review(s) available for sumatriptan and morphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Refractory obsessive-compulsive disorder: state-of-the-art treatment.
Topics: Antipsychotic Agents; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Fluvoxamine; Humans; Morphine; Multicenter Studies as Topic; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Practice Guidelines as Topic; Retrospective Studies; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Sumatriptan; Treatment Outcome | 2002 |
1 trial(s) available for sumatriptan and morphine
| Article | Year |
|---|---|
Psychoactivity and abuse potential of sumatriptan.
Topics: Adult; Affect; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Indoles; Male; Middle Aged; Morphine; Serotonin Receptor Agonists; Substance-Related Disorders; Sulfonamides; Sumatriptan; Surveys and Questionnaires | 1992 |
18 other study(ies) available for sumatriptan and morphine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
Topics: Analgesics, Opioid; HEK293 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Organic Cation Transporter 1; Permeability; Protein Conformation | 2019 |
Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression.
Topics: Animals; Brain; Cortical Spreading Depression; Immunohistochemistry; Injections; Male; Morphine; Narcotics; Potassium Chloride; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Sumatriptan; Tissue Distribution; Trigeminal Caudal Nucleus | 1997 |
[Particular features of the impact of certain vegetotropic drugs on the excitability of cholinergic structures, contractile myocardial function and electromotive stomach activity].
Topics: Animals; Autonomic Nervous System; Bretylium Tosylate; Heart; Morphine; Motor Activity; Myocardial Contraction; Propranolol; Rabbits; Rats; Receptors, Cholinergic; Receptors, Serotonin, 5-HT3; Stomach; Sumatriptan | 2005 |
Recurrent headache due to MS plaque.
Topics: Analgesics, Opioid; Anti-Inflammatory Agents; Female; Headache; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Morphine; Multiple Sclerosis; Procaine; Spinal Cord; Sumatriptan | 2008 |
Sumatriptan effects on morphine-induced antinociceptive tolerance and physical dependence: The role of nitric oxide.
Topics: Analgesics; Animals; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Naloxone; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Sumatriptan | 2018 |
Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
Topics: Analgesics; Analgesics, Opioid; Animals; Headache Disorders, Secondary; Hyperalgesia; Male; Migraine Disorders; Morphine; Rats; Rats, Sprague-Dawley; Repetition Priming; Serotonin 5-HT1 Receptor Agonists; Sumatriptan | 2019 |
Segmental Hair Analysis-Interpretation of the Time of Drug Intake in Two Patients Undergoing Drug Treatment.
Topics: Acetaminophen; Adult; Analgesics; Antiemetics; Azabicyclo Compounds; Citalopram; Female; Forensic Toxicology; Hair; Humans; Hypnotics and Sedatives; Metoclopramide; Morphine; Oxazepam; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sumatriptan; Tramadol; Vasoconstrictor Agents | 2019 |
Delta opioid receptor agonists are effective for multiple types of headache disorders.
Topics: Animals; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Headache Disorders; Hyperalgesia; Male; Mice; Morphine; Nitroglycerin; Piperazines; Receptors, Opioid, delta; Sumatriptan | 2019 |